Zikria Dean reported VBIO

Source

Document

SEC Form 4

Publisher

U.S. Securities and Exchange Commission (EDGAR)

Document ID

0001683168-26-007398

Machine-readable

Structured copy

Timestamps

Event (reported)

Sep 22, 2026

Published

Sep 24, 2026

Ingested by INSIDER

Nov 5, 02:15 UTC

Last re-read

Nov 5, 02:15 UTC

Extracted facts

Filer

Zikria Dean

Role

Director, Interim CEO

Transaction

Grant or awardAs filed: “A”

Asset

Valion Bio, Inc. — Restricted Stock Units

Ticker

VBIO

Shares

50.0K

Price per share

$0

Execution date (reported)

Sep 22, 2026

Owned after transaction

50.0K shares

Days from execution to publication

2

What this establishes

Zikria Dean filed this Form 4 reporting a grant or award of VBIO on Sep 22, 2026. It became public on Sep 24, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

Extraction

Method

Form 4 XML

Confidence

1.00

Director, Interim CEO

Zikria Deancik:0001877611

Issuer

Valion Bio, Inc.cik:0001787740

Revision history · 0

No field has changed since this record was first ingested.